Alpha Teknova (TKNO) Competitors $7.73 +0.49 (+6.77%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends TKNO vs. HRMY, GLPG, XNCR, EVO, ARQT, RCUS, NRIX, KNSA, IMCR, and OCULShould you be buying Alpha Teknova stock or one of its competitors? The main competitors of Alpha Teknova include Harmony Biosciences (HRMY), Galapagos (GLPG), Xencor (XNCR), Evotec (EVO), Arcutis Biotherapeutics (ARQT), Arcus Biosciences (RCUS), Nurix Therapeutics (NRIX), Kiniksa Pharmaceuticals (KNSA), Immunocore (IMCR), and Ocular Therapeutix (OCUL). These companies are all part of the "pharmaceutical products" industry. Alpha Teknova vs. Harmony Biosciences Galapagos Xencor Evotec Arcutis Biotherapeutics Arcus Biosciences Nurix Therapeutics Kiniksa Pharmaceuticals Immunocore Ocular Therapeutix Alpha Teknova (NASDAQ:TKNO) and Harmony Biosciences (NASDAQ:HRMY) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, community ranking, profitability, institutional ownership, media sentiment, analyst recommendations, risk and dividends. Does the MarketBeat Community prefer TKNO or HRMY? Harmony Biosciences received 46 more outperform votes than Alpha Teknova when rated by MarketBeat users. Likewise, 66.67% of users gave Harmony Biosciences an outperform vote while only 36.36% of users gave Alpha Teknova an outperform vote. CompanyUnderperformOutperformAlpha TeknovaOutperform Votes836.36% Underperform Votes1463.64% Harmony BiosciencesOutperform Votes5466.67% Underperform Votes2733.33% Do institutionals & insiders hold more shares of TKNO or HRMY? 13.8% of Alpha Teknova shares are owned by institutional investors. Comparatively, 86.2% of Harmony Biosciences shares are owned by institutional investors. 15.2% of Alpha Teknova shares are owned by insiders. Comparatively, 30.8% of Harmony Biosciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has preferable valuation and earnings, TKNO or HRMY? Harmony Biosciences has higher revenue and earnings than Alpha Teknova. Alpha Teknova is trading at a lower price-to-earnings ratio than Harmony Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlpha Teknova$36.35M11.34-$36.78M-$0.74-10.45Harmony Biosciences$681.88M2.87$128.85M$2.1116.25 Is TKNO or HRMY more profitable? Harmony Biosciences has a net margin of 17.98% compared to Alpha Teknova's net margin of -87.17%. Harmony Biosciences' return on equity of 23.16% beat Alpha Teknova's return on equity.Company Net Margins Return on Equity Return on Assets Alpha Teknova-87.17% -35.30% -24.52% Harmony Biosciences 17.98%23.16%14.24% Which has more volatility and risk, TKNO or HRMY? Alpha Teknova has a beta of 0.37, suggesting that its stock price is 63% less volatile than the S&P 500. Comparatively, Harmony Biosciences has a beta of 0.79, suggesting that its stock price is 21% less volatile than the S&P 500. Do analysts rate TKNO or HRMY? Alpha Teknova currently has a consensus target price of $5.00, suggesting a potential downside of 35.32%. Harmony Biosciences has a consensus target price of $49.80, suggesting a potential upside of 45.27%. Given Harmony Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Harmony Biosciences is more favorable than Alpha Teknova.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alpha Teknova 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Harmony Biosciences 2 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.60 Does the media prefer TKNO or HRMY? In the previous week, Harmony Biosciences had 12 more articles in the media than Alpha Teknova. MarketBeat recorded 12 mentions for Harmony Biosciences and 0 mentions for Alpha Teknova. Harmony Biosciences' average media sentiment score of 0.84 beat Alpha Teknova's score of 0.00 indicating that Harmony Biosciences is being referred to more favorably in the news media. Company Overall Sentiment Alpha Teknova Neutral Harmony Biosciences Positive SummaryHarmony Biosciences beats Alpha Teknova on 17 of the 18 factors compared between the two stocks. Ad Weiss RatingsBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $125,000 by the end of his first month in office.This could be his favorite coin. Get Alpha Teknova News Delivered to You Automatically Sign up to receive the latest news and ratings for TKNO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TKNO vs. The Competition Export to ExcelMetricAlpha TeknovaDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$412.07M$2.51B$5.12B$9.07BDividend YieldN/A0.73%4.91%4.22%P/E Ratio-10.456.0791.3417.19Price / Sales11.3475.081,117.70116.80Price / CashN/A15.0542.6437.86Price / Book3.503.284.794.78Net Income-$36.78M$29.98M$120.07M$225.60M7 Day Performance-3.74%-1.55%-1.90%-1.23%1 Month Performance6.18%8.21%11.45%3.37%1 Year Performance124.06%-21.46%30.63%16.58% Alpha Teknova Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TKNOAlpha Teknova0.4718 of 5 stars$7.73+6.8%$5.00-35.3%+124.1%$412.07M$36.35M-10.45240Gap UpHRMYHarmony Biosciences4.7827 of 5 stars$32.80+1.3%$47.00+43.3%+7.0%$1.87B$681.88M15.35200Analyst ForecastAnalyst RevisionGLPGGalapagos0.6163 of 5 stars$26.99+0.6%$30.75+13.9%-31.4%$1.78B$260.09M0.001,123XNCRXencor4.3204 of 5 stars$24.72+2.9%$36.56+47.9%+18.4%$1.73B$168.34M-7.51280EVOEvotec2.387 of 5 stars$4.68+4.2%$5.93+26.8%-60.5%$1.66B$777.05M0.005,061Positive NewsARQTArcutis Biotherapeutics0.8599 of 5 stars$13.32+5.0%$15.50+16.4%+478.8%$1.56B$138.71M-7.58150Options VolumeRCUSArcus Biosciences2.6476 of 5 stars$16.43+2.2%$34.00+106.9%-9.3%$1.50B$117M-5.11500News CoverageNRIXNurix Therapeutics2.5066 of 5 stars$21.07+3.9%$30.35+44.1%+101.7%$1.49B$56.42M-6.97300News CoverageKNSAKiniksa Pharmaceuticals2.5299 of 5 stars$20.33+0.6%$36.60+80.0%+15.4%$1.47B$384.10M-147.36220Positive NewsIMCRImmunocore2.4974 of 5 stars$29.22+1.1%$65.64+124.6%-51.4%$1.46B$296.31M-30.43497Short Interest ↓OCULOcular Therapeutix3.6452 of 5 stars$8.95+3.0%$16.71+86.8%+116.8%$1.41B$58.44M0.00267Positive News Related Companies and Tools Related Companies HRMY Competitors GLPG Competitors XNCR Competitors EVO Competitors ARQT Competitors RCUS Competitors NRIX Competitors KNSA Competitors IMCR Competitors OCUL Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TKNO) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Teknova, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Teknova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
